The impact of microsatellite instability on the molecular phenotype of colorectal tumors

Yuriko Mori, Florin M. Selaru, Fumiaki Sato, Jing Yin, Lisa A. Simms, Yan Xu, Andreea Olaru, Elena Deacu, Suna Wang, Jennifer M. Taylor, Joanne Young, Barbara Leggett, Jeremy R. Jass, John M. Abraham, David Shibata, Stephen J. Meltzer

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Frequent microsatellite instability MSI (MSI-H) occurring in human tumors is characterized by defective DNA mismatch repair and unique clinical features. However, infrequent MSI (MSI-L) has not been attributable to any other defined molecular pathway, and its existence as a biologically distinct category has been challenged. Moreover, the global molecular phenotypes (GMPs) underlying MSI-H, MSI-L, or microsatellite-stable (MSS) tumors have never been evaluated. To evaluate the impact of MSI status on GMP and to determine the importance of MSI relative to other molecular and clinical features, cDNA microarray-derived data from 41 colon cancers were interpreted using principal components analysis. The clinically relevant principal component with the greatest impact on GMP was component 3, which distinguished MSI-H from non-MSI-H (i.e., MSI-L and microsatellite stable) tumors and was designated the MSI-H separator. Notably, MSI-L cancers were also clearly distinguished from non-MSI-L tumors by another principle component, component 10 (the "MSI-L separator"). This second finding validates the existence of MSI-L tumors as a distinct molecular phenotypic category. Thus, both components 3 and 10 reflected different aspects of MSI and helped to establish principal components analysis as a useful tool to identify and characterize distinct biological features of human malignancy.

Original languageEnglish (US)
Pages (from-to)4577-4582
Number of pages6
JournalCancer Research
Volume63
Issue number15
StatePublished - Aug 1 2003

Fingerprint

Microsatellite Instability
Colorectal Neoplasms
Phenotype
Neoplasms
N-methylsuccinimide
Principal Component Analysis
Microsatellite Repeats
DNA Mismatch Repair
Oligonucleotide Array Sequence Analysis
Colonic Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Mori, Y., Selaru, F. M., Sato, F., Yin, J., Simms, L. A., Xu, Y., ... Meltzer, S. J. (2003). The impact of microsatellite instability on the molecular phenotype of colorectal tumors. Cancer Research, 63(15), 4577-4582.

The impact of microsatellite instability on the molecular phenotype of colorectal tumors. / Mori, Yuriko; Selaru, Florin M.; Sato, Fumiaki; Yin, Jing; Simms, Lisa A.; Xu, Yan; Olaru, Andreea; Deacu, Elena; Wang, Suna; Taylor, Jennifer M.; Young, Joanne; Leggett, Barbara; Jass, Jeremy R.; Abraham, John M.; Shibata, David; Meltzer, Stephen J.

In: Cancer Research, Vol. 63, No. 15, 01.08.2003, p. 4577-4582.

Research output: Contribution to journalArticle

Mori, Y, Selaru, FM, Sato, F, Yin, J, Simms, LA, Xu, Y, Olaru, A, Deacu, E, Wang, S, Taylor, JM, Young, J, Leggett, B, Jass, JR, Abraham, JM, Shibata, D & Meltzer, SJ 2003, 'The impact of microsatellite instability on the molecular phenotype of colorectal tumors', Cancer Research, vol. 63, no. 15, pp. 4577-4582.
Mori Y, Selaru FM, Sato F, Yin J, Simms LA, Xu Y et al. The impact of microsatellite instability on the molecular phenotype of colorectal tumors. Cancer Research. 2003 Aug 1;63(15):4577-4582.
Mori, Yuriko ; Selaru, Florin M. ; Sato, Fumiaki ; Yin, Jing ; Simms, Lisa A. ; Xu, Yan ; Olaru, Andreea ; Deacu, Elena ; Wang, Suna ; Taylor, Jennifer M. ; Young, Joanne ; Leggett, Barbara ; Jass, Jeremy R. ; Abraham, John M. ; Shibata, David ; Meltzer, Stephen J. / The impact of microsatellite instability on the molecular phenotype of colorectal tumors. In: Cancer Research. 2003 ; Vol. 63, No. 15. pp. 4577-4582.
@article{c588eb8a5c534cc991d544306d66c9a0,
title = "The impact of microsatellite instability on the molecular phenotype of colorectal tumors",
abstract = "Frequent microsatellite instability MSI (MSI-H) occurring in human tumors is characterized by defective DNA mismatch repair and unique clinical features. However, infrequent MSI (MSI-L) has not been attributable to any other defined molecular pathway, and its existence as a biologically distinct category has been challenged. Moreover, the global molecular phenotypes (GMPs) underlying MSI-H, MSI-L, or microsatellite-stable (MSS) tumors have never been evaluated. To evaluate the impact of MSI status on GMP and to determine the importance of MSI relative to other molecular and clinical features, cDNA microarray-derived data from 41 colon cancers were interpreted using principal components analysis. The clinically relevant principal component with the greatest impact on GMP was component 3, which distinguished MSI-H from non-MSI-H (i.e., MSI-L and microsatellite stable) tumors and was designated the MSI-H separator. Notably, MSI-L cancers were also clearly distinguished from non-MSI-L tumors by another principle component, component 10 (the {"}MSI-L separator{"}). This second finding validates the existence of MSI-L tumors as a distinct molecular phenotypic category. Thus, both components 3 and 10 reflected different aspects of MSI and helped to establish principal components analysis as a useful tool to identify and characterize distinct biological features of human malignancy.",
author = "Yuriko Mori and Selaru, {Florin M.} and Fumiaki Sato and Jing Yin and Simms, {Lisa A.} and Yan Xu and Andreea Olaru and Elena Deacu and Suna Wang and Taylor, {Jennifer M.} and Joanne Young and Barbara Leggett and Jass, {Jeremy R.} and Abraham, {John M.} and David Shibata and Meltzer, {Stephen J.}",
year = "2003",
month = "8",
day = "1",
language = "English (US)",
volume = "63",
pages = "4577--4582",
journal = "Cancer Research",
issn = "0008-5472",
number = "15",

}

TY - JOUR

T1 - The impact of microsatellite instability on the molecular phenotype of colorectal tumors

AU - Mori, Yuriko

AU - Selaru, Florin M.

AU - Sato, Fumiaki

AU - Yin, Jing

AU - Simms, Lisa A.

AU - Xu, Yan

AU - Olaru, Andreea

AU - Deacu, Elena

AU - Wang, Suna

AU - Taylor, Jennifer M.

AU - Young, Joanne

AU - Leggett, Barbara

AU - Jass, Jeremy R.

AU - Abraham, John M.

AU - Shibata, David

AU - Meltzer, Stephen J.

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Frequent microsatellite instability MSI (MSI-H) occurring in human tumors is characterized by defective DNA mismatch repair and unique clinical features. However, infrequent MSI (MSI-L) has not been attributable to any other defined molecular pathway, and its existence as a biologically distinct category has been challenged. Moreover, the global molecular phenotypes (GMPs) underlying MSI-H, MSI-L, or microsatellite-stable (MSS) tumors have never been evaluated. To evaluate the impact of MSI status on GMP and to determine the importance of MSI relative to other molecular and clinical features, cDNA microarray-derived data from 41 colon cancers were interpreted using principal components analysis. The clinically relevant principal component with the greatest impact on GMP was component 3, which distinguished MSI-H from non-MSI-H (i.e., MSI-L and microsatellite stable) tumors and was designated the MSI-H separator. Notably, MSI-L cancers were also clearly distinguished from non-MSI-L tumors by another principle component, component 10 (the "MSI-L separator"). This second finding validates the existence of MSI-L tumors as a distinct molecular phenotypic category. Thus, both components 3 and 10 reflected different aspects of MSI and helped to establish principal components analysis as a useful tool to identify and characterize distinct biological features of human malignancy.

AB - Frequent microsatellite instability MSI (MSI-H) occurring in human tumors is characterized by defective DNA mismatch repair and unique clinical features. However, infrequent MSI (MSI-L) has not been attributable to any other defined molecular pathway, and its existence as a biologically distinct category has been challenged. Moreover, the global molecular phenotypes (GMPs) underlying MSI-H, MSI-L, or microsatellite-stable (MSS) tumors have never been evaluated. To evaluate the impact of MSI status on GMP and to determine the importance of MSI relative to other molecular and clinical features, cDNA microarray-derived data from 41 colon cancers were interpreted using principal components analysis. The clinically relevant principal component with the greatest impact on GMP was component 3, which distinguished MSI-H from non-MSI-H (i.e., MSI-L and microsatellite stable) tumors and was designated the MSI-H separator. Notably, MSI-L cancers were also clearly distinguished from non-MSI-L tumors by another principle component, component 10 (the "MSI-L separator"). This second finding validates the existence of MSI-L tumors as a distinct molecular phenotypic category. Thus, both components 3 and 10 reflected different aspects of MSI and helped to establish principal components analysis as a useful tool to identify and characterize distinct biological features of human malignancy.

UR - http://www.scopus.com/inward/record.url?scp=0041633909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041633909&partnerID=8YFLogxK

M3 - Article

VL - 63

SP - 4577

EP - 4582

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 15

ER -